Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021) Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al. Conference contribution Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115) (2021) Gruenwald V, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al. Conference contribution Region of interest optimization for radiation therapy of breast cancer (2021) Sauer TO, Ott O, Lahmer G, Fietkau R, Bert C Journal article High-grade salivary gland cancer: is surgery followed by radiotherapy an adequate treatment to reach tumor control? Results from a tertiary referral centre focussing on incidence and management of distant metastases (2021) Freitag V, Lettmaier S, Semrau S, Hecht M, Mantsopoulos K, Müller-Hübner S, Traxdorf M, et al. Journal article Radioimmuntherapie (2021) Hecht M, Gaipl U, Fietkau R Journal article, Review article Low- vs. high-dose radiotherapy in Graves’ ophthalmopathy: a retrospective comparison of long-term results (2021) Weissmann T, Lettmaier S, Donaubauer AJ, Bert C, Schmidt M, Kruse F, Ott O, et al. Journal article A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma (2021) Twelves C, Sabel M, Checketts D, Miller S, Tayo B, Jove M, Brazil L, et al. Journal article Quality assurance for dynamic tumor tracking (2021) Witulla B, Ziegler M, Brandt T, Prasetio H, Fietkau R, Bert C Journal article Differences in and Prognostic Value of Quality of Life Data in Rectal Cancer Patients with and without Distant Metastases (2021) Frank F, Hecht M, Loy F, Rutzner S, Fietkau R, Distel L Journal article Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward (2021) Krug D, Baumann R, Combs SE, Duma MN, Dunst J, Feyer P, Fietkau R, et al. Journal article, Review article